Usefulness of corticosteroid therapy for protein-losing enteropathy after the Fontan procedure - PubMed (original) (raw)

Case Reports

. 1991 Sep 15;68(8):819-21.

doi: 10.1016/0002-9149(91)90667-a.

Affiliations

• PMID: 1892099
• DOI: 10.1016/0002-9149(91)90667-a

Free article

Case Reports

Usefulness of corticosteroid therapy for protein-losing enteropathy after the Fontan procedure

J Rychik et al. Am J Cardiol. 1991.

Free article

No abstract available

PubMed Disclaimer

Similar articles

• Heparin therapy and reversal of protein-losing enteropathy in a case with congenital heart disease.
  Bendayán I, Casaldaliga J, Castelló F, Miró L. Bendayán I, et al. Pediatr Cardiol. 2000 May-Jun;21(3):267-8. doi: 10.1007/s002460010055. Pediatr Cardiol. 2000. PMID: 10818189
• Protein-losing enteropathy following the Fontan operation: resolution with prednisone therapy.
  Rothman A, Snyder J. Rothman A, et al. Am Heart J. 1991 Feb;121(2 Pt 1):618-9. doi: 10.1016/0002-8703(91)90743-2. Am Heart J. 1991. PMID: 1990777 No abstract available.
• Protein-losing enteropathy complicating the Mustard procedure.
  Krueger SK, Burney DW, Ferlic RM. Krueger SK, et al. Surgery. 1977 Mar;81(3):305-6. Surgery. 1977. PMID: 841466
• Protein-losing enteropathy in systemic lupus erythematosus.
  Tanaka T, Damião AO, Gabriel Júnior A, Missi SM, Rodrigues CJ, Nobre MR, Sipahi AM, Yoshinari NH. Tanaka T, et al. Rev Hosp Clin Fac Med Sao Paulo. 1991 Jan-Feb;46(1):34-7. Rev Hosp Clin Fac Med Sao Paulo. 1991. PMID: 1843003 Review.
• Advances in the surgical management of congenital heart disease in infants and children.
  Pacifico AD, McKay R. Pacifico AD, et al. Cardiovasc Clin. 1981;12(3):127-41. Cardiovasc Clin. 1981. PMID: 7044538 Review. No abstract available.

Cited by

• Protein-Losing Enteropathy and Gastropathy.
  Landzberg BR, Pochapin MB. Landzberg BR, et al. Curr Treat Options Gastroenterol. 2001 Feb;4(1):39-49. doi: 10.1007/s11938-001-0045-z. Curr Treat Options Gastroenterol. 2001. PMID: 11177680
• The Fontan pathway: What's down the road?
  Khambadkone S. Khambadkone S. Ann Pediatr Cardiol. 2008 Jul;1(2):83-92. doi: 10.4103/0974-2069.43872. Ann Pediatr Cardiol. 2008. PMID: 20300248 Free PMC article.
• Significance of circulating hepatocyte growth factor in protein-losing enteropathy after Fontan operation.
  Kim GB, Kwon BS, Bae EJ, Noh CI, Choi JY. Kim GB, et al. Pediatr Cardiol. 2011 Oct;32(7):917-23. doi: 10.1007/s00246-011-0014-9. Epub 2011 Jun 11. Pediatr Cardiol. 2011. PMID: 21667184
• Prevalence of Subclinical Enteric Alpha-1-Antitrypsin Loss in Children with Univentricular Circulation Following Total Cavopulmonary Connection.
  Breatnach CR, Cleary A, Prendiville T, Crumlish K, Murchan H, McMahon CJ. Breatnach CR, et al. Pediatr Cardiol. 2018 Jan;39(1):33-37. doi: 10.1007/s00246-017-1720-8. Epub 2017 Sep 6. Pediatr Cardiol. 2018. PMID: 28879464
• The Use of Fecal Calprotectin Levels in the Fontan population.
  Miranda C, Taqatqa A, Chapa-Rodriguez A, Holton JP, Awad SM. Miranda C, et al. Pediatr Cardiol. 2018 Mar;39(3):591-594. doi: 10.1007/s00246-017-1796-1. Epub 2017 Dec 28. Pediatr Cardiol. 2018. PMID: 29282492

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Medical

  • MedlinePlus Health Information